Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
about
Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modelingA review of 3D image-based dosimetry, technical considerations and emerging perspectives in (90)Y microsphere therapy.Peptide receptor therapies in neuroendocrine tumors.Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.Internal radiotherapy techniques using radiolanthanide praseodymium-142: a review of production routes, brachytherapy, unsealed source therapy.Yttrium-labelled peptides for therapy of NET.The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy.Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.Determination of Organ Doses in Radioiodine Therapy using Monte Carlo Simulation.Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors.From fixed activities to personalized treatments in radionuclide therapy: lost in translation?Rational evaluation of the therapeutic effect and dosimetry of auger electrons for radionuclide therapy in a cell culture model.Dosimetry in clinical radionuclide therapy: the devil is in the detail.Biodistribution and tolerance of intravenous iodine-131-labelled hypericin in healthy dogs.Experimental facts supporting a red marrow uptake due to radiometal transchelation in 90Y-DOTATOC therapy and relationship to the decrease of platelet counts.Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature reviewInter-comparison of quantitative imaging of lutetium-177 (Lu) in European hospitals
P2860
Q33768719-24A86CD6-5C3A-41BC-912A-E0FE250F306AQ35825755-0D08E303-4FCF-4BA2-925D-E1E7027BF364Q36899620-3DE72A83-6001-4A59-B772-C8161C0C9B73Q37563878-B10EC058-AED0-4E98-8BA3-945F9F4604A7Q37864159-520FB2AE-7098-4579-AC7D-887213A5DA5DQ37896510-C5FE6B36-CA0F-405A-943E-7A28898B628CQ37990401-B558771A-ADD2-4D8D-869C-2AF1EC995039Q38219225-8BA363A4-7DCF-4EC7-8783-B1F68E5BA6F5Q38612027-434978CB-A369-4C14-A813-F5F4ECC9F135Q41881786-B0D95957-EFDB-49B5-BA59-826AF9901498Q44355651-5AD16640-2C05-482D-902B-830DF29F3E71Q47124130-0ABDEB49-1B1A-406C-9F7D-3CF73EC65108Q47251568-44C1A920-802C-42EE-9C85-AD29AE26F68DQ48097399-8022B9B5-8BC7-4E05-AFAB-C13AE03A98DAQ48286237-D4996EA3-AFF4-48AF-B673-608E1A396237Q50545742-254AEF8C-CACD-4E5B-83CC-96E46F10D213Q58695846-A08F9E42-ED94-4E60-B41D-41FBD0B976DAQ58803949-46E8BB78-C466-4636-9828-1A8F973F7CDD
P2860
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
@ast
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
@en
type
label
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
@ast
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
@en
prefLabel
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
@ast
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
@en
P2093
P2860
P921
P1476
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray"
@en
P2093
P2860
P2888
P304
P356
10.1007/S00259-006-0338-5
P50
P577
2007-05-01T00:00:00Z